Evidence map›Paper›PMID 42004601›Full record

ReviewFrontiers in pharmacology2026

Recent advances in tendon redox biology: the interplay of oxidative stress, calcium signaling, and antioxidant defence mechanisms.

Yejiang Tang, Ahmad Alhaskawi, Bing Ruan, Zhenli Yuan

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yejiang Tang *Department of Emergency, Zhuji People's Hospital, Zhuji, Zhejiang, China.
Ahmad Alhaskawi *Department of Orthopedics, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Bing RuanDepartment of Infection Disease, Zhuji People's Hospital, Zhuji, Zhejiang, China.
Zhenli YuanDepartment of Thoracic Surgery, Zhuji People's Hospital, Zhuji, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tendon injuries are increasingly recognized as conditions driven not only by mechanical overload but also by complex molecular imbalances, particularly involving oxidative stress. Recent evidence highlights the central role of reactive oxygen species (ROS), originating primarily from mitochondrial respiration and NADPH oxidase activation, in regulating cellular responses during tendon injury and repair. Mechanical loading and calcium signaling further influence ROS dynamics, exacerbating oxidative damage or modulating adaptive responses depending on context. Tendon cells counteract oxidative insults through a coordinated antioxidant defense network, including superoxide dismutases, catalase, glutathione peroxidases, and peroxiredoxins. However, in pathological states such as tendinopathy or diabetes, this redox balance is often disrupted, leading to sustained inflammation, extracellular matrix degradation, and impaired healing. This review synthesizes current findings on ROS generation, redox-sensitive signaling pathways, and the functional consequences of oxidative stress in tendon biology. Furthermore, it explores therapeutic strategies targeting redox imbalance, including pharmacological antioxidants and bioengineered scaffolds with antioxidant properties. Understanding these mechanisms provides critical insights into tendon pathophysiology and highlights promising avenues for redox-based regenerative therapies.

Indexed as

antioxidant defensemitochondriaNADPH oxidaseoxidative stressreactive oxygen speciestendon injury

Identifiers

PMID42004601
PMCPMC13083024

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.